Neurocrine menaikkan panduan penjualan INGREZZA 2026 menjadi $2,825 miliar-$2,875 miliar sembari mengintegrasikan VYKAT XR (NASDAQ:NBIX)
· seekingalpha.com
Panggilan pendapatan Q2 2026 Neurocrine (NBIX): penjualan $950 juta+, kenaikan panduan INGREZZA, integrasi VYKAT XR, katalis 2027—baca poin-poin utamanya.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...